Bluejay Diagnostics, Inc.
BJDX
$1.47
$0.021.38%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.74M | -7.25M | -7.72M | -8.59M | -9.40M |
| Total Depreciation and Amortization | 181.40K | 196.70K | 199.10K | 217.90K | 435.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -308.00K | 6.70K | 17.30K | 503.10K | 268.70K |
| Change in Net Operating Assets | -47.30K | 280.60K | -383.50K | -1.06M | 583.30K |
| Cash from Operations | -6.91M | -6.77M | -7.89M | -8.92M | -8.12M |
| Capital Expenditure | -1.30K | -271.30K | -306.70K | -393.50K | -467.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.30K | -271.30K | -306.70K | -393.50K | -467.80K |
| Total Debt Issued | 0.00 | 2.00M | 2.00M | 2.00M | 2.00M |
| Total Debt Repaid | -87.20K | -1.94M | -1.94M | -2.23M | -1.86M |
| Issuance of Common Stock | 3.85M | 8.57M | 12.07M | 12.07M | 13.66M |
| Repurchase of Common Stock | -400.00 | -400.00 | -400.00 | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -464.70K | -1.13M | -1.84M | -1.85M | -2.26M |
| Cash from Financing | 3.30M | 7.50M | 10.29M | 10.00M | 11.54M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.62M | 454.90K | 2.09M | 678.80K | 2.96M |